Acadia Healthcare: Why I Am Selling The Rally (Rating Downgrade)
Acadia Healthcare Company, Inc. has been downgraded to a Sell rating due to ongoing structural challenges and a significant increase in valuation. Despite leadership changes and reduced capital expenditures, the company continues to face margin pressures from rising insurance costs and claim frequency. Its heavy reliance on Medicaid, which accounts for over 60% of revenue, is also seen as a risk amid potential reimbursement cuts after 2028.
- ▪Acadia Healthcare Company, Inc. is downgraded to Sell due to structural issues and elevated valuation.
- ▪The company faces a 200+ basis point margin disadvantage from higher insurance costs and increasing claim frequency.
- ▪Medicaid accounts for 60.7% of Acadia's revenue, exposing it to risks from the OBBBA and potential rate declines after 2028.
- ▪Valuation metrics are stretched compared to industry peers, raising concerns about sustainability of the current stock rally.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4896947-acadia-healthcare-why-i-am-selling-the-rally-rating-downgrade"},"author":{"@type":"Person","name":"Stephen…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.